Related Experiment Video
Updated: Aug 16, 2025

Protocol and Guidelines for Point-of-Care Lung Ultrasound in Diagnosing Neonatal Pulmonary Diseases Based on International Expert Consensus
Published on: March 6, 2019
Minimal important difference in childhood interstitial lung diseases
Matthias Griese1, Nicolaus Schwerk2, Julia Carlens2
1Munich University Hospital, Dr von Hauner Children's Hospital, German Center for Lung Research (DZL), Munchen, Germany matthias.griese@med.uni-muenchen.de.
Insights
This study establishes minimal important differences (MIDs) for vital signs and health-related quality of life (HrQoL) in childhood interstitial lung diseases (chILD). These findings aid clinicians in monitoring chILD progression and treatment effectiveness.
Area of Science:
- Pediatric Pulmonology
- Clinical Research
- Rare Diseases
Background:
- Monitoring disease progression in childhood interstitial lung diseases (chILD) is crucial for effective patient management.
- Minimal important difference (MID) data, representing the smallest clinically significant change, were previously unavailable for chILD vital signs and health-related quality of life (HrQoL).
Purpose of the Study:
- To calculate and report MIDs for vital signs and HrQoL scores in a large cohort of children with chILD.
- To provide clinicians with essential benchmarks for assessing treatment efficacy and disease progression in chILD patients.
Main Methods:
- Utilized data from the Kids Lung Register, a web-based platform for rare pediatric lung disorders.
- Calculated MIDs using both distribution-based (one-third SD) and anchor-based methods, with lung function parameters serving as anchors.
- Collected data on vital signs (respiratory rate, oxygen saturation, Fan severity score) and various HrQoL questionnaires.
Main Results:
- Established MIDs for respiratory rate (1.3 z-score), oxygen saturation (3.0%), and Fan severity score (0.2-0.4).
- Determined MIDs for HrQoL scores, including the Health Status Questionnaire (0.4-0.8), chILD-specific questionnaire (4.4%-8.2%), and PedsQL V.4.0 subscores and total score.
- Responsiveness analysis results generally aligned with the calculated MIDs.
Conclusions:
- This study provides the first estimates of MIDs for vital signs and HrQoL in a substantial chILD cohort.
- These MIDs serve as valuable tools for clinicians to interpret changes in patient status and make informed treatment decisions in chILD.
Background:
Monitoring disease progression in childhood interstitial lung diseases (chILD) is essential. No information for the minimal important difference (MID), which is defined as the smallest change in a parameter that is perceived as important prompting a clinician to change the treatment, is available. We calculated MIDs for vital signs (respiratory rate, peripheral oxygen saturation in room air, Fan severity score) and health-related quality of life (HrQoL) scores.
Methods:
This study used data from the Kids Lung Register, which is a web-based management platform that collects data of rare paediatric lung disorders with a focus on chILD. Data of vital signs and HrQoL scores (Health Status Questionnaire, chILD-specific questionnaire and PedsQL V.4.0) were collected. MIDs were calculated according to distribution-based (one-third SD) and anchor-based methods (using forced expiratory volume in 1 s and forced vital capacity) as anchors.
Results:
Baseline data of 774 children were used to calculate the following MIDs: respiratory rate 1.3 (z-score), O2 saturation in room air 3.0%, Fan severity score 0.2-0.4, Health Status Questionnaire 0.4-0.8, chILD-specific questionnaire 4.4%-8.2%, physical health summary score 7.8%-8.9%, psychosocial health summary score 3.4%-6.9% and total score 5.1%-7.4%. Results of the responsiveness analysis generally agreed with the MIDs calculated.
Conclusions:
For the first time, we provide estimates of MIDs for vital signs and HrQoL scores in a large cohort of chILD using different methods.
Related Concept Videos
Chronic Obstructive Pulmonary Disease-I: Introduction
Pulmonary Cycle: Exhalation
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History

